EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epigallocatechin-3-gallate inhibits the collagen accumulation of oral submucous fibrosis induced by arecoline

Ge Gao, Caipeng Lin, Ruibo Li, Xi Xie, Hai-Bin Luo

Frontiers in Pharmacology · 31.01.2025 · 16

DOI: 10.3389/fphar.2025.1540559 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 31.01.2025. Verfasst von Ge Gao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Tropical Biological Resources of Ministry of Education and Hainan Engineering Research Center for Drug Screening and Evaluation, Sc…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Oral submucous fibrosis (OSF) is a chronic oral mucosal disease, which exerts a profound impact on patients’ daily life and currently lacks efficacious therapeutic interventions. Epigallocatechin-3-gallate (EGCG), the abundant polyphenol found in green tea, exhibits remarkable anti-fibrotic effects on the skin. However, the research on OSF regarding EGCG is relatively limited.

Purpose

We aimed to investigate the potential therapeutic effect of EGCG against OSF using an arecoline (ARE) -induced rat model and primary rat oral fibroblasts.

Methods

Primary rat oral mucosal fibroblasts (ROMF) were isolated and identified. Optimal ARE concentrations were established using the Cell Counting Kit-8. The impact of ARE on extracellular matrix (ECM)-related protein expression was assessed through RT-qPCR and Western blot techniques. Similarly, the effects of EGCG on ARE-induced ECM changes in ROMF were evaluated. The study also established an OSF model in Sprague-Dawley rats, induced by ARE, with pathological changes characterized using HE and Masson’s staining, further assessing the impact of ARE on ECM-related protein expression in rat oral tissues through RT-qPCR and Western blot methods.

Results

EGCG effectively suppressed the ARE-induced ECM components while concurrently improving the OSF pathological process in vitro and in vivo .

Conclusion

The results indicate that the natural product EGCG effectively suppressed the increased ECM components induced by ARE and concurrently improved the OSF pathological process, indicating that EGCG could be potentially a novel anti-fibrotic candidate drug for the treatment of OSF.

Schlagwörter

Stichwörter der Autor:innen

arecolineepigallocatechin-3-gallateextracellular matrixgreen teaoral submucous fibrosis

Autor:innen und Institutionen

  • Key Laboratory of Tropical Biological Resources of Ministry of Education and Hainan Engineering Research Center for Drug Screening and Evaluation, School of Pharmaceutical Sciences, Hainan University, Haikou, China.
  • School of Life and Health Sciences, Hainan University, Haikou, China.
  • Song Li's Academician Workstation of Hainan University (School of Pharmaceutical Sciences), Sanya, China.

Zitieren

APA

Gao, G., Lin, C., Li, R., Xie, X., & Luo, H. B. (2025). Epigallocatechin-3-gallate inhibits the collagen accumulation of oral submucous fibrosis induced by arecoline. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1540559

Vancouver

Gao G, Lin C, Li R, Xie X, Luo HB. Epigallocatechin-3-gallate inhibits the collagen accumulation of oral submucous fibrosis induced by arecoline. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1540559

BibTeX
@article{Gao2025,
  author = {Gao, Ge and Lin, Caipeng and Li, Ruibo and Xie, Xi and Luo, Hai-Bin},
  title = {Epigallocatechin-3-gallate inhibits the collagen accumulation of oral submucous fibrosis induced by arecoline},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fphar.2025.1540559}
}
Kostenlos starten →